NANT CANCER VACCINE
Live / Registered — Registered (as of 19 Nov 2024)
What this means for you
Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97800703
- Registration number
- 7573522
- Mark type
- Stylized text
- Filed
- 17 Feb 2023
- Published for opposition
- 08 Aug 2023
- Registered
- 19 Nov 2024
- Attorney of record
- Michael J. McCue
Goods and services
- Class 044 — Medical, beauty and agricultural services: medical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immuneoncology, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines biologics, cells and cell-derived preparations; providing medical and health information relating to pharmaceuticals, oncology, cancer, immuneoncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines, biologics, cells, and cell-derived preparations
Owner
- Nant Holdings IP, LLC, Culver City, CA, US
- Nant Holdings IP, LLC, Culver City, CA, US
- Nant Holdings IP, LLC, Culver City, CA, US
Prior registrations
Prosecution history
- 19 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 15 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jul 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Jul 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 22 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Apr 2024 — NON-FINAL ACTION E-MAILED
- 22 Apr 2024 — SU - NON-FINAL ACTION - WRITTEN
- 19 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Apr 2024 — USE AMENDMENT FILED
- 19 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL